Built for enterprise-approved AI tools · Public sessions use anonymised PharmAI Pro case material · Company governance remains the authority

AI workflow capability for commercial pharma

Turn enterprise AI access into practical capability across commercial pharma.

PharmAI Pro helps Marketing and Insights & Analytics teams use enterprise-approved AI tools in the work they already run — from brand planning and insight synthesis to forecasting, analytical builds and leadership readouts.

Private team sessions. Selected public cohorts. Selective advisory for defined workflows.

Works with enterprise-approved AI environments

  • Microsoft Copilot
  • ChatGPT
  • Claude
  • Gemini
  • Internal & other approved AI

The same workflow method works across platforms. Your company’s tool, data-use and review policies remain the authority.

Anonymised example
Brand Plan Situation & Decision Brief
  • What changed
  • So-what for the brand
  • Decisions forced
Anonymised example
SWOT & Strategic Priority Map
  • Evidence-anchored SWOT
  • Strategic priorities
  • Initiative choices
Anonymised example
Launch Strategy & Readiness Pack
  • Critical assumptions
  • Readiness gates
  • Decision triggers
Anonymised example
Customer Insight & Positioning Readout
  • Segment needs
  • Positioning options
  • Evidence gaps
Anonymised example
Competitor Response Scenario
  • Event & impact
  • Response options
  • Monitoring triggers
Anonymised example
Agency & Omnichannel Brief
  • Objective & barrier
  • Channel roles
  • Success measures

Illustrative structures only. Public sessions use anonymised PharmAI Pro case material.

Function tracks

Start with the function. Build capability around real work.

Flagship brand-team track

Marketing

Build annual brand plans, challenge launch and positioning choices, convert customer insight into strategy, prepare agency and omnichannel briefs, anticipate MLR questions and sharpen brand-team readouts.

Explore Marketing
Commercial decision-cycle track

Insights & Analytics

Prepare performance reviews, challenge forecast assumptions, build launch and competitor scenarios, synthesise market research and turn evidence into brand and leadership decisions.

Explore Insights & Analytics
In development

Market Access

Potential workflows include payer environment scanning, payer objection mapping, value story stress-testing, HTA input synthesis and country adaptation.

Register interest

The gap is no longer AI access. It is useful workflow.

Generic AI enablement

  • Tool features and broad prompting
  • Generic, cross-industry examples
  • One-off outputs
  • Limited evidence and review discipline
  • Teams translate the learning themselves

PharmAI Pro

  • Function-specific pharma workflows
  • Reusable workflow and prompt architecture
  • Evidence, QA and human-review handoffs
  • Built around enterprise-approved tools
  • Outputs used in real decisions

One operating model. Different workflows by function.

The method stays consistent; inputs, evidence standards, workflow risks and outputs change by function.

01
Frame

Set context, audience, constraints and the decision the work must support.

02
Generate

Produce structured, workflow-specific output with a reusable prompt architecture.

03
Validate

Check evidence, assumptions, gaps and risk before anything moves forward.

04
Apply

Turn output into the handoffs the team already owns.

05
Communicate

Land the decision ask with leadership and cross-functional partners.

Session formats

Choose the depth that fits the team.

01Discover

Function Workflow Briefing

30 minutes · Complimentary
  • One workflow concept explained in function context
  • One anonymised example
  • Priority discussion for the team's current cycle
  • A recommended next step

Boundary: Not a training session. No workflow or prompt library is provided.

02Inspire

Workflow Inspiration & Prioritisation Session

2 hours · Paid · private team session
  • Three to five worked workflow examples
  • Enterprise-safe application discussion
  • Opportunity mapping against the team's real work
  • A prioritised shortlist of workflows to pursue

Boundary: Does not include the complete workflow library or the participant pack.

03Apply

Workflow Masterclass + bounded application follow-up

4 hours + follow-up clinic · Paid flagship · private team or selected public cohort
  • Selected hands-on workflows run end to end
  • Reusable workflow architecture and participant assets
  • Frame → Generate → Validate → Apply → Communicate applied throughout
  • Two-Week Implementation Path and one shared application clinic

Boundary: Does not include confidential output review or ongoing consulting.

Not just prompts. Reusable outputs for real decision work.

InputAI-assisted workflowHuman validationReusable output
Brand Plan Situation and Decision Brief

The planning situation, what changed and the decisions it forces, in one structured brief.

Evidence-Anchored SWOT and Strategic Priority Map

Explicit choices and priorities, each traceable to the evidence behind them.

Launch Strategy and Readiness Assumption Pack

Critical assumptions, readiness gates and the decision triggers that follow from them.

Customer Insight, Segmentation and Positioning Readout

Research and field input converted into segment needs, positioning and message choices.

Competitor Response Scenario and Monitoring Plan

Response options, affected assumptions and what is only monitored for now.

Agency and Omnichannel Campaign Brief

Objective, audience, channel roles, content logic and measurement in a briefable form.

For teams

Private team sessions and selective advisory.

Most work runs as a private session for one function or brand team, shaped around the cycle the team is entering. Selective advisory is available for a defined workflow with an agreed scope.

Built for governed pharma environments.

  • Public sessions use synthetic or anonymised PharmAI Pro case material. Participants do not bring company documents.
  • Internal application happens only inside company-approved AI environments, under the company's own policies and controls.
  • Only inputs permitted by company policy are used. Sensitive, patient-level, unpublished clinical and confidential commercial information stays out of scope.
  • PharmAI Pro does not replace Medical, Legal, Regulatory, MLR, analytical validation, forecast governance or final business accountability.

Governance decisions remain with the company. PharmAI Pro works within the tools, policies and review processes the organisation already operates.

Founder / Facilitator

Built by a pharma commercial and analytics operator — not an AI generalist.

Michał Lubas is a senior pharma commercial, marketing analytics, forecasting and insights leader with global and regional experience. PharmAI Pro is built from recurring planning, synthesis, analytical and leadership workflows commercial teams already run.

Michał Lubas, Founder and Facilitator of PharmAI Pro
Michał Lubas
Founder & Facilitator, PharmAI Pro

Start with your function. Choose the depth. Apply one workflow.